HealthEquity, Inc. (NASDAQ:HQY) Shares Purchased by Grandeur Peak Global Advisors LLC

Grandeur Peak Global Advisors LLC grew its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 3.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 130,377 shares of the company's stock after buying an additional 4,566 shares during the quarter. HealthEquity accounts for approximately 1.1% of Grandeur Peak Global Advisors LLC's portfolio, making the stock its 28th biggest position. Grandeur Peak Global Advisors LLC owned approximately 0.15% of HealthEquity worth $12,510,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in HQY. EP Wealth Advisors LLC acquired a new stake in HealthEquity during the third quarter worth approximately $340,000. Public Employees Retirement System of Ohio increased its position in HealthEquity by 5.6% during the third quarter. Public Employees Retirement System of Ohio now owns 91,754 shares of the company's stock worth $7,510,000 after buying an additional 4,878 shares during the period. Barclays PLC boosted its holdings in shares of HealthEquity by 209.3% in the third quarter. Barclays PLC now owns 166,492 shares of the company's stock valued at $13,628,000 after acquiring an additional 112,667 shares during the period. M&T Bank Corp raised its position in HealthEquity by 0.7% in the 3rd quarter. M&T Bank Corp now owns 49,447 shares of the company's stock valued at $4,047,000 after purchasing an additional 321 shares during the last quarter. Finally, Geode Capital Management LLC raised its position in HealthEquity by 0.7% in the 3rd quarter. Geode Capital Management LLC now owns 2,078,977 shares of the company's stock valued at $170,197,000 after purchasing an additional 15,145 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Remove Ads

HealthEquity Price Performance

HQY traded down $0.33 on Tuesday, hitting $83.03. 644,192 shares of the company were exchanged, compared to its average volume of 761,763. The business's fifty day moving average is $96.47 and its 200 day moving average is $96.35. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm has a market capitalization of $7.18 billion, a P/E ratio of 76.17, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49.

Analyst Ratings Changes

A number of research analysts have commented on the stock. The Goldman Sachs Group dropped their price objective on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Raymond James raised HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price objective for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. KeyCorp decreased their price target on HealthEquity from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Monday, March 24th. Finally, Barrington Research reiterated an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research report on Friday. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $112.58.

Insider Buying and Selling

In other news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company's stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 20,381 shares of company stock worth $1,781,432 in the last quarter. Company insiders own 2.20% of the company's stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.